These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Smothering dystonia in a patient with oromandibular dystonia. Grill S Mov Disord; 2004 Nov; 19(11):1374-5. PubMed ID: 15389989 [TBL] [Abstract][Full Text] [Related]
25. Severe post-herpetic neuralgia successfully treated with botulinum toxin A: three case reports. Sotiriou E; Apalla Z; Panagiotidou D; Ioannidis D Acta Derm Venereol; 2009; 89(2):214-5. PubMed ID: 19326024 [No Abstract] [Full Text] [Related]
26. [Effects of treatment of spasmodic torticollis by neurovascular decompression, myotomy, and toxin type A: a comparative study]. Sun KH; Lu YC; Hu GH; Luo C; Hou LJ; Chen JX; Zhou J Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):21-4. PubMed ID: 19489238 [TBL] [Abstract][Full Text] [Related]
28. [Applications of botulinum toxin in ophthalmology]. Lanzl I; Merté RL; Roggenkämper P Klin Monbl Augenheilkd; 2009 Jan; 226(1):R1-8; quiz R9-12. PubMed ID: 19173157 [No Abstract] [Full Text] [Related]
29. Botulinum toxin A injections for the treatment of Schwartz-Jampel syndrome: a case series. Aburahma SK; Al-Khateeb T; Alrefai A; Amarin Z J Child Neurol; 2009 Jan; 24(1):5-8. PubMed ID: 19168812 [TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease. Melo A; Rodrigues B; Nóbrega AC J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803 [No Abstract] [Full Text] [Related]
31. Gene dosage influences the age at onset of SCA2 in a family from southern Italy. Spadafora P; Annesi G; Liguori M; Tarantino P; Cutuli N; Carrideo S; Cirò Candiano IC; De Marco EV; Civitelli D; Annesi F; Giuffrida S; Quattrone A Clin Genet; 2007 Oct; 72(4):381-3. PubMed ID: 17850638 [No Abstract] [Full Text] [Related]
32. Use of an oral sensory feedback device in the management of jaw-opening dystonia. Verma SP; Sinha UK Otolaryngol Head Neck Surg; 2009 Jul; 141(1):142-3. PubMed ID: 19559975 [No Abstract] [Full Text] [Related]
33. The expanding role of botulinum toxin type A injections in the management of children with cerebral palsy. Carr LJ Dev Med Child Neurol; 2009 Sep; 51(9):687-8. PubMed ID: 19709139 [No Abstract] [Full Text] [Related]
34. Does botulinum toxin prevent or promote deformity in children with cerebral palsy? Gough M Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839 [No Abstract] [Full Text] [Related]
35. Multiple eccrine hidrocystomas--from diagnosis to treatment: the role of dermatoscopy and botulinum toxin. Correia O; Duarte AF; Barros AM; Rocha N Dermatology; 2009; 219(1):77-9. PubMed ID: 19420900 [TBL] [Abstract][Full Text] [Related]
36. Letter to the editor on 'Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials'. Idrovo AJ; Albavera-Hernández C; Rodríguez JM Clin Rehabil; 2009 Sep; 23(9):862-3. PubMed ID: 19713401 [No Abstract] [Full Text] [Related]
37. Differences in botulinum toxins: time to end the confusion. Brin MF; Tan K; Gallagher C J Cosmet Laser Ther; 2009 Sep; 11(3):180-1. PubMed ID: 19626521 [No Abstract] [Full Text] [Related]
38. Dystonic reaction after Botox injection under nitrous oxide/oxygen and sevoflurane anesthesia. Abdallah C; Hannallah R Paediatr Anaesth; 2009 Mar; 19(3):269-71. PubMed ID: 19236647 [No Abstract] [Full Text] [Related]
39. [Botulinic toxin of type A in the treatment of prostatic adenoma and cancer]. Mazo EB; Krivoborodov GG; Shkol'nikov ME; Efremov NS Urologiia; 2008; (4):63-6. PubMed ID: 19058365 [No Abstract] [Full Text] [Related]
40. Are nongenetic triggers for dystonia type-specific? A study exploring scoliosis in blepharospasm. Martino D; Defazio G; Abbruzzese G; Marchese R; Fabbrini G; Decembrino V; Berardelli A Mov Disord; 2007 Mar; 22(4):576-8. PubMed ID: 17260341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]